Rating History for Stoke Therapeutics (STOK) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/13/2026 | Kevin Strang | New Coverage | Buy (N/A) |
44.00 (N/A) |
31.38 (29.05) |
-7.43% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/13/2026 | Kevin Strang | New Coverage | Buy (N/A) |
44.00 (N/A) |
31.38 (29.05) |
-7.43% | Details |